156 related articles for article (PubMed ID: 19472443)
1. High-resolution melting facilitates mutation screening of PYGM in patients with McArdle disease.
Duno M; Quinlivan R; Vissing J; Schwartz M
Ann Hum Genet; 2009 May; 73(Pt 3):292-7. PubMed ID: 19472443
[TBL] [Abstract][Full Text] [Related]
2. A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
Rubio JC; Garcia-Consuegra I; Nogales-Gadea G; Blazquez A; Cabello A; Lucia A; Andreu AL; Arenas J; Martin MA
Hum Mutat; 2007 Feb; 28(2):203-4. PubMed ID: 17221871
[TBL] [Abstract][Full Text] [Related]
3. Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease.
Inal-Gültekin G; Toptaş-Hekimoğlu B; Görmez Z; Gelişin Ö; Durmuş H; Ergüner B; Demirci H; Sağıroğlu MŞ; Parman Y; Deymeer F; Yılmaz-Aydoğan H; Pençe S; Bekircan-Kurt CE; Tan E; Erdem-Özdamar S; Üstek D; Giger U; Öztürk O; Serdaroğlu-Oflazer P
Neuromuscul Disord; 2017 Nov; 27(11):997-1008. PubMed ID: 28967462
[TBL] [Abstract][Full Text] [Related]
4. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL
Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558
[TBL] [Abstract][Full Text] [Related]
5. Absence of p.R50X
Tarrasó G; Real-Martinez A; Parés M; Romero-Cortadellas L; Puigros L; Moya L; de Luna N; Brull A; Martín MA; Arenas J; Lucia A; Andreu AL; Barquinero J; Vissing J; Krag TO; Pinós T
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848135
[TBL] [Abstract][Full Text] [Related]
6. McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene.
Nogales-Gadea G; Brull A; Santalla A; Andreu AL; Arenas J; Martín MA; Lucia A; de Luna N; Pinós T
Hum Mutat; 2015 Jul; 36(7):669-78. PubMed ID: 25914343
[TBL] [Abstract][Full Text] [Related]
7. Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon.
Birch KE; Quinlivan RM; Morris GE
Neuromuscul Disord; 2013 Jan; 23(1):43-51. PubMed ID: 22818872
[TBL] [Abstract][Full Text] [Related]
8. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
[TBL] [Abstract][Full Text] [Related]
9. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
[TBL] [Abstract][Full Text] [Related]
10. A new rare mutation (691delCC/insAAA) in exon 17 of the PYGM gene causing McArdle disease.
Quintans B; Sanchez-Andrade A; Teijeira S; Fernandez-Hojas R; Rivas E; López MJ; Navarro C
Arch Neurol; 2004 Jul; 61(7):1108-10. PubMed ID: 15262743
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle disease.
Isackson PJ; Tarnopolsky M; Vladutiu GD
Mol Genet Metab; 2005 Jul; 85(3):239-42. PubMed ID: 15979037
[TBL] [Abstract][Full Text] [Related]
12. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.
Bruno C; Cassandrini D; Martinuzzi A; Toscano A; Moggio M; Morandi L; Servidei S; Mongini T; Angelini C; Musumeci O; Comi GP; Lamperti C; Filosto M; Zara F; Minetti C
Hum Mutat; 2006 Jul; 27(7):718. PubMed ID: 16786513
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in patients with McArdle disease by analysis of skeletal muscle mRNA.
García-Consuegra I; Rubio JC; Nogales-Gadea G; Bautista J; Jiménez S; Cabello A; Lucía A; Andreu AL; Arenas J; Martin MA
J Med Genet; 2009 Mar; 46(3):198-202. PubMed ID: 19251976
[TBL] [Abstract][Full Text] [Related]
14. A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay.
Sohn EH; Kim HS; Lee AY; Fukuda T; Sugie H; Kim DS
Neuromuscul Disord; 2008 Nov; 18(11):886-9. PubMed ID: 18667317
[TBL] [Abstract][Full Text] [Related]
15. Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern.
Wu Y; Weber JL; Vladutiu GD; Tarnopolsky MA
Mol Genet Metab; 2011 Dec; 104(4):587-91. PubMed ID: 21880526
[TBL] [Abstract][Full Text] [Related]
16. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay.
Nogales-Gadea G; Rubio JC; Fernandez-Cadenas I; Garcia-Consuegra I; Lucia A; Cabello A; Garcia-Arumi E; Arenas J; Andreu AL; Martín MA
Hum Mutat; 2008 Feb; 29(2):277-83. PubMed ID: 17994553
[TBL] [Abstract][Full Text] [Related]
17. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; San Millán B; Navarro C
Hum Genet; 2009 Apr; 125(3):349. PubMed ID: 19320035
[No Abstract] [Full Text] [Related]
18. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Millán BS; Navarro C
Hum Genet; 2009 Apr; 125(3):343. PubMed ID: 19320018
[No Abstract] [Full Text] [Related]
19. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Millán BS; Navarro C
Hum Genet; 2009 Apr; 125(3):339. PubMed ID: 19309786
[No Abstract] [Full Text] [Related]
20. McArdle disease: molecular genetic update.
Andreu AL; Nogales-Gadea G; Cassandrini D; Arenas J; Bruno C
Acta Myol; 2007 Jul; 26(1):53-7. PubMed ID: 17915571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]